The global demand for Anticoagulant Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Anticoagulants, generally called blood thinners, are chemical materials that prohibit or curtail coagulation of blood and lengthen the clotting period. Anticoagulants are used to abolish the chances of blood clots in the body. Blood clots are built when platelets glue together and proteins present in the blood bind together to create a solid lump. Anticoagulants cease the platelets from binding to one another and clotting proteins from adhering together. The market offers various types of anticoagulant drugs, and each drug functions by deterring various paths of blood coagulation. These drugs are primarily used for the high threat of blood clots, deep vein thrombosis, pulmonary embolism, and others. Besides, they are commonly used in the treatment of pulmonary embolism, atrial fibrillation, and managing the risk of stroke.
The global anticoagulants market is anticipated to grow at a substantial rate in the coming years, with the increasing plurality of diseases such as venous thromboembolism and cardiovascular disease across the globe. Moreover, the growing adoption of new oral anticoagulants, and maturing awareness of new techniques is boosting the market growth. Similarly, expanding obesity problems and geriatric population with the growing demand for contemporary therapeutics are predicted to affect the growth of the global anticoagulant market during the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of anticoagulant.
The entire anticoagulant market has been sub-categorized into drug class, route of administration and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Drug Class
By Route Of Administration
- Heparin & LMWH
- Vitamin K Antagonist
- Injectable Anticoagulant
- Oral Anticoagulant
- Atrial Fibrillation
- Pulmonary Embolism (PE)
- Deep Vein Thrombosis (DVT)
This section covers regional segmentation which accentuates on current and future demand for anticoagulant market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Anticoagulant Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the anticoagulant market include Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals, Inc., among others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.